Premium
[P1–051]: RESULTS FROM A 3‐MONTH STUDY IN HEALTHY SUBJECTS AGED 60 YEARS WITH THE BACE INHIBITOR CNP520
Author(s) -
Ufer Mike,
RouzadeDominguez MarieLaure,
Huledal Gunilla,
Pezous Nicole,
Graf Ana,
LopezLopez Cristina,
Neumann Ulf,
Vormfelde Stefan Viktor,
Legangneux Eric
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.118
Subject(s) - tolerability , placebo , medicine , pharmacokinetics , adverse effect , asymptomatic , dose ranging study , anesthesia , gastroenterology , double blind , pathology , alternative medicine